Keyphrases
Estrogen Receptor
100%
Uterus
100%
Uterine Cells
100%
Receptor Turnover
100%
Aziridine
29%
Turning over
11%
Rat Uterus
11%
Human Breast Cancer Cells
5%
Amino Acids
5%
Monoclonal Antibody
5%
Normal Density
5%
Incubation
5%
Polyacrylamide Gel
5%
Estrogen
5%
Phenyl
5%
MCF-7
5%
Pulse-chase Experiment
5%
Aged Rats
5%
Protein Synthesis
5%
Ethoxy
5%
Primary Culture
5%
Cycloheximide
5%
Estradiol
5%
In Vivo Conditions
5%
Immunoblot Analysis
5%
Diphenyl
5%
Sodium Dodecyl Sulfate
5%
Intact Cells
5%
Intact Rats
5%
Cell Sensitivity
5%
Nuclear Estrogen Receptor
5%
Affinity Labeling
5%
Sucrose Gradient
5%
Rapid Turnover
5%
Density Shift
5%
Receptor Sensitivity
5%
Butene
5%
Immunology and Microbiology
Dynamics
100%
Monoclonal Antibody
50%
Cancer Cell
50%
Western Blot
50%
Target Cell
50%
Pulse Rate
50%
Protein Synthesis
50%
Primary Culture
50%
Sucrose Gradient
50%
Affinity Labeling
50%
Amino Acid
50%
Neuroscience
In Vitro
100%
In Vivo
100%
Estrogen Receptor
100%
Receptor
33%
Tamoxifen
27%
Amino Acid
5%
Polyacrylamide
5%
Primary Culture
5%
Cycloheximide
5%
Monoclonal Antibody
5%
Protein Biosynthesis
5%
Sodium Dodecyl Sulfate
5%
Diethylstilbestrol
5%
Immunoblotting
5%
Biochemistry, Genetics and Molecular Biology
Dynamics
100%
Estrogen Receptor
100%
Amino Acids
5%
Cancer Cell
5%
Pulse Rate
5%
Target Cell
5%
Protein Biosynthesis
5%
Monoclonal Antibody
5%
Primary Culture
5%
Sodium Dodecyl Sulfate
5%
Cycloheximide
5%
Sucrose Gradient
5%
Affinity Label
5%
Estradiol
5%
Immunoblotting
5%
Butene
5%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Receptor
33%
Tamoxifen Aziridine
27%
Breast Cancer
5%
Amino Acid
5%
Monoclonal Antibody
5%
Polyacrylamide Gel
5%
Western Blot
5%
Diethylstilbestrol
5%
Carbon 13
5%
Nitrogen 15
5%
Primary Culture
5%
Sodium Dodecyl Sulfate
5%
Cycloheximide
5%
Nuclear Estrogen
5%
Biphenyl
5%
Veterinary Science and Veterinary Medicine
Estrogen Receptor
100%
Tamoxifen
27%
Rat
22%
Cancer Cell
5%
Nuclear Estrogen
5%
Target Cell
5%
Diethylstilbestrol
5%
Monoclonal Antibody
5%
Breast Cancer
5%